Avandia May Benefit Overweight Type 1s


By: Daniel Trecroci

Overweight type 1s may improve their blood glucose control without increasingtheir insulin dosage by supplementing their control regimen with the type 2insulin-sensitizing drug Avandia (rosiglitazone), say Dallas, Texas,researchers.

A total of 50 adult type 1s with a body mass index of 27 were randomlyassigned to take insulin and placebo or insulin and 4 milligrams of Avandiatwice daily for a period of eight months. The treatment goal in both groups wasto achieve near-normal glucose levels.

A1C levels in both groups improved significantly. The total daily insulindose decreased slightly in subjects taking Avandia an average of 77.5 to 75.3units.

The incidence of weight gain and of hypoglycemia did not differ between thetwo treatment groups.

Diabetes Care, July 2005



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.